Related Experiment Video
Updated: Jan 23, 2026

In Silico Clinical Trials for Cardiovascular Disease
Published on: May 27, 2022
Aortic Stenosis and Heart Failure: Disease Ascertainment and Statistical Considerations for Clinical Trials
Ernest Spitzer1,2, Rebecca T Hahn3,4, Philippe Pibarot5
1Thoraxcenter, Erasmus University Medical Center Rotterdam, the Netherlands.
Abstract:
Aortic stenosis is a progressive disease that develops over decades, and once symptomatic and untreated, is associated with poor survival. Transcatheter aortic valve replacement has evolved significantly in the past decade and has expanded its indication from surgically inoperable and high-risk patients to patients with intermediate risk. Assessment of heart failure-related outcomes include the use of functional assessments, disease-specific quality of life surveys and standardised ascertainment of events, such as hospitalisations. Multiple statistical approaches are currently being tested to account for recurrent events such as hospitalisations for heart failure or to combine binary and continuous outcomes, both intended to assess the holistic burden of the disease, as opposed to the traditional analysis of time to first event.
Related Concept Videos
Statistical Software for Data Analysis and Clinical Trials
Heart Failure III: Clinical Manifestations
Clinical Trials
There are four phases in a clinical trial. A phase one...
Clinical Trials: Overview
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Heart Failure II: Pathophysiology

